selected publications
-
Durable medication-free remission of sarcoidosis following discontinuation of anti-tumor necrosis factor-α therapy.
Respiratory medicine.
2022
Academic Article
GET IT
Times cited: 1 - Treatment of sarcoidosis in US rheumatology practices: data from the American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) Registry: comment on article by Hamman et al. Arthritis care & research. 2022 Letter GET IT
- Granulomatous disease and the two faces of Janus: divergent effects of tofacitinib therapy for inflammatory arthritis. Clinical and experimental rheumatology. 2021 Letter GET IT
- When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic. Chest. 2020 Editorial Article GET IT
-
Drugs for cognitive loss and dementia.
The Medical letter on drugs and therapeutics.
2017
Academic Article
GET IT
Times cited: 5 -
Pilot study of a multidisciplinary gout patient education and monitoring program.
Seminars in arthritis and rheumatism.
2016
Academic Article
GET IT
Times cited: 32 -
Sarcoidosis: Rheumatology perspective.
Best practice & research. Clinical rheumatology.
2016
Review
GET IT
Times cited: 11 -
The CY domain of the Fcgamma RIa alpha-chain (CD64) alters gamma-chain tyrosine-based signaling and phagocytosis.
The Journal of biological chemistry.
2002
Academic Article
GET IT
Times cited: 18 -
Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2000
Academic Article
GET IT
Times cited: 144 -
The cytoplasmic domain of human FcgammaRIa alters the functional properties of the FcgammaRI.gamma-chain receptor complex.
The Journal of biological chemistry.
1999
Academic Article
GET IT
Times cited: 32 -
Fc gammaRIIA polymorphism as a risk factor for invasive pneumococcal infections in systemic lupus erythematosus.
Arthritis and rheumatism.
1997
Academic Article
GET IT
Times cited: 55 -
Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile.
The Journal of experimental medicine.
1989
Academic Article
GET IT
Times cited: 19